Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$19.47 - $28.49 $5.03 Million - $7.36 Million
-258,497 Reduced 50.0%
258,498 $5.87 Million
Q3 2022

Nov 14, 2022

SELL
$22.51 - $34.32 $8.93 Million - $13.6 Million
-396,794 Reduced 43.42%
516,995 $13.5 Million
Q2 2022

Aug 15, 2022

BUY
$16.0 - $45.99 $6.67 Million - $19.2 Million
417,114 Added 83.98%
913,789 $20.1 Million
Q1 2022

May 16, 2022

SELL
$33.17 - $46.98 $3.39 Million - $4.81 Million
-102,334 Reduced 17.08%
496,675 $22.3 Million
Q3 2021

Nov 15, 2021

SELL
$60.13 - $77.6 $12 Million - $15.5 Million
-200,000 Reduced 25.03%
599,009 $39.8 Million
Q4 2020

Feb 16, 2021

BUY
$43.6 - $73.05 $2.41 Million - $4.04 Million
55,367 Added 7.45%
799,009 $53.7 Million
Q3 2020

Nov 16, 2020

SELL
$38.47 - $52.03 $2.3 Million - $3.11 Million
-59,868 Reduced 7.45%
743,642 $38.3 Million
Q2 2020

Aug 14, 2020

BUY
$27.28 - $43.01 $2.88 Million - $4.53 Million
105,392 Added 15.1%
803,510 $30.3 Million
Q1 2020

May 15, 2020

BUY
$23.08 - $35.53 $1.55 Million - $2.38 Million
67,046 Added 10.62%
698,118 $20.8 Million
Q4 2019

Feb 14, 2020

SELL
$15.74 - $35.04 $1.79 Million - $3.99 Million
-113,973 Reduced 15.3%
631,072 $21.7 Million
Q3 2019

Nov 14, 2019

BUY
$18.09 - $27.92 $13.5 Million - $20.8 Million
745,045 New
745,045 $13.5 Million

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $750M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Rtw Investments, LP Portfolio

Follow Rtw Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.